Cite
HARVARD Citation
Shimony, S. et al. (2021). Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients – a multicenter retrospective observational study. Leukemia & lymphoma. 62 (10), pp. 2475-2481. [Online].